$47.91
-$0.58
(-1.20%)
Quote as of 4:02 PM EST on 02/10/12
Valeant Pharmaceuticals Intern...
NYSE:VRX
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer
Mylan Acquires Two Generics - Analyst Blog
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
10 Pharma Stocks to Add to Your Portfolio…Stat
Mylan Completes Acquisition Of Two Limited-Competition Dermatological Products From Valeant
AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board
Mylan Buys Two Dermatology Drugs from Valeant
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
Valeant Pharmaceuticals acquires Probiotica in Brazil
Valeant withdraws acquisition offer for Ista
ISTA's Board Reiterates Commitment to Maximizing Shareholder Value Through Strategic Review Process
Valeant to syndicate $500-million credit line
Ista board updates strategic review process
ISTA Pharma (ISTA) About 6% Lowe; Valeant (VRX) Withdraws Offer
Valeant Pharmaceuticals to Syndicate Senior Secured Term Loan Credit Facility
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Neutral
Valeant downgraded to Neutral from Overweight at Piper Jaffray
Valeant Includes OTCs In Bid For Dramatic Growth By 2013
Where To Invest: Valeant Pharma Rises, Outlook Good
The Salix Story Keeps Improving (SLXP, FRX, ENDP, NKTR)
Valeant Increases Hostile Bid for Ista to $7.50 a Share
Valeant raises offer for Ista Pharmaceuticals(2)
Valeant Hikes Offer for Drug Maker Ista
Stocks Surge as Investors Shrug Off European Woes
Notable Mergers and Acquisitions of the Day 1/17: [(CNVO)/BLKB) (ISTA)/(VRX) (VQ)]
Fleming Pharmaceuticals Sells Ocean, Nephrocaps, Other Branded Products To Valeant
Salix, Valeant Display Possible Entry Points
Fleming Pharmaceuticals Sells Ocean, Nephrocaps, Other Branded Products to Valeant
Valeant Provides 2012 Roadmap - Analyst Blog
Morgan Stanley Upgrades Valeant Pharmaceuticals (VRX) to Overweight
